Suicide gene therapy of graft-versus-host disease: Immune reconstitution with transplanted mature T cells

Blood

Volumn 98, Issue 7, 2001, Pages 2071-2076

  Cohen, José L ^a   Boyer, Olivier ^a   Klatzmann, David ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ALLOIMMUNITY; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIVISION; CELL KILLING; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG CONFORMATION; DRUG PROTEIN BINDING; FEMALE; GENE THERAPY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE RESPONSE; IMMUNE SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUICIDE GENE; T LYMPHOCYTE;

EID: 0035496944     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.7.2071     Document Type: Article

References (28)

1. Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood. 1993;82:2585-2594.
2. Mackall CL, Gress RE. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev. 1997;157:61-72.
3. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555-562.
4. Roux E, Dumont-Girard F, Starobinski M, et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood. 2000;96:2299- 2303.
5. Thomas E, Storb R, Clift RA, et al. Bone-marrow transplantation. N Engl J Med. 1975;292:832-843.
6. Cohen JL, Boyer O, Klatzmann D. Would suicide gene therapy solve the T-cell dilemma of allogeneic bone marrow transplantation? Immunol Today. 1999;20:172-176.
7. Tiberghien P, Reynolds CW, Keller J, et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood. 1994; 84:1333-1341.
8. Cohen JL, Boyer O, Salomon B, et al. Fertile homozygous transgenic mice expressing a functional truncated herpes simplex thymidine kinase TK gene. Transgenic Res. 1998;7:321-330.
9. Cohen JL, Boyer O, Salomon B et al. Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes. Blood. 1997;89:4636-4645.
10. Cohen JL, Boyer O, Thomas-Vaslin V, Klatzmann D. Suicide-gene mediated modulation of graft-versus-host disease. Leuk Lymphoma. 1999;34: 473-480.
11. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity. 1999;11:173-181.
12. + T cells in lymphopenic hosts. Immunity. 1999;11: 183-190.
13. + T cells. J Immunol. 1997;159:3383-3390.
14. Cohen JL, Charlotte F, Lejeune L, Martin PJ, Klatzmann D, Boyer O. Immunological defects after suicide gene therapy of experimental graft-versus-host disease. Hum Gene Ther. 1999;10: 2710-2717.
15. Cohen JL, Saron MF, Boyer O, et al. Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host disease. Hum Gene Ther. 2000;11:2473-2481.
16. Cochet M, Pannetier C, Regnault A, Darche S, Leclerc C, Kourilsky P. Molecular detection and in vivo analysis of the specific T cell response to a protein antigen. Eur J Immunol. 1992;22:2639-2647.
17. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A. 1993;90:4319-4323.
18. Boyer O, Cohen JL, Bellier B, Thomas-Vaslin V, Klatzmann D, Saron MF. Transient control of a virus-induced immunopathology by genetic immunosuppression. Gene Ther. 2000;7:1536-1542.
19. Dulude G, Roy DC, Perrault C. The effect of graft-versus-host disease on T cell production and homeostasis. J Exp Med. 1999;189:1329-1341.
20. Helene M, Lake-Bullock V, Bryson JS, Jennings CD, Kaplan AM. Inhibition of graft-versus-host disease: use of a T cell-controlled suicide gene. J Immunol. 1997;158:5079-5082.
21. Contassot E, Ferrand C, Angonin R, et al. Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting. Transplantation. 2000;69: 503-508.
22. Bonini C, Ferrari G, Verzeletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 1997;276:1719-1724.
23. Tiberghien P, Ferrand C, Lioure B, et al. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood. 2001;97:63-72.
24. Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med. 1998; 339:1186-1193.
25. Korngold R, Sprent J. Negative selection of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers: role of the H-2 complex. J Exp Med. 1980;151:1114- 1124.
26. Brochu S, Rioux-Masse B, Roy J, Roy DC, Perreault C. Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease. Blood. 1999;94:390-400.
27. Martin PJ, Hansen JA, Buckner CD, et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts, Blood. 1985;66: 664-672.
28. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol. 1996;156:4609-4616.